To further assess the clinical relevance of HANR expression in patients with CRC, we divided the 165 patient samples according to their levels of HANR expression (HANR-high or HANR-low; n = 83 and 82, respectively) based on the median HANR expression level in CRC tumor tissue samples. The gene discussed is RPL13AP20; the disease is neoplasm.